[go: up one dir, main page]

RU96102509A - METHOD FOR INCREASING ANTITUMOR EFFICIENCY IN EXPERIMENT - Google Patents

METHOD FOR INCREASING ANTITUMOR EFFICIENCY IN EXPERIMENT

Info

Publication number
RU96102509A
RU96102509A RU96102509/14A RU96102509A RU96102509A RU 96102509 A RU96102509 A RU 96102509A RU 96102509/14 A RU96102509/14 A RU 96102509/14A RU 96102509 A RU96102509 A RU 96102509A RU 96102509 A RU96102509 A RU 96102509A
Authority
RU
Russia
Prior art keywords
experiment
increasing
increasing antitumor
antitumor efficiency
antitumor
Prior art date
Application number
RU96102509/14A
Other languages
Russian (ru)
Other versions
RU2135178C1 (en
Inventor
Ю.Н. Бордюшков
Л.Д. Кирсанова
Original Assignee
Ростовский научно-исследовательский онкологический институт
Ю.Н. Бордюшков
Л.Д. Кирсанова
Filing date
Publication date
Application filed by Ростовский научно-исследовательский онкологический институт, Ю.Н. Бордюшков, Л.Д. Кирсанова filed Critical Ростовский научно-исследовательский онкологический институт
Priority to RU96102509A priority Critical patent/RU2135178C1/en
Priority claimed from RU96102509A external-priority patent/RU2135178C1/en
Publication of RU96102509A publication Critical patent/RU96102509A/en
Application granted granted Critical
Publication of RU2135178C1 publication Critical patent/RU2135178C1/en

Links

Claims (1)

Способ повышения противоопухолевой эффективности в эксперименте, включающий введение противоопухолевых препаратов, отличающийся тем, что, с целью снижения токсического влияния цитостатиков без уменьшения их противоопухолевого действия, общетерапевтические дозы препарата вводят в селезенку на фоне предшествующего внутрибрюшинного введения индометацина в суммарной дозе 6 мг.A method of increasing antitumor efficacy in an experiment, including the introduction of antitumor drugs, characterized in that, in order to reduce the toxic effect of cytostatics without reducing their antitumor effect, general therapeutic doses of the drug are injected into the spleen against the background of a previous intraperitoneal injection of indomethacin in a total dose of 6 mg.
RU96102509A 1996-02-12 1996-02-12 Method of increasing antitumor efficiency in experiment RU2135178C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96102509A RU2135178C1 (en) 1996-02-12 1996-02-12 Method of increasing antitumor efficiency in experiment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96102509A RU2135178C1 (en) 1996-02-12 1996-02-12 Method of increasing antitumor efficiency in experiment

Publications (2)

Publication Number Publication Date
RU96102509A true RU96102509A (en) 1998-05-10
RU2135178C1 RU2135178C1 (en) 1999-08-27

Family

ID=20176736

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96102509A RU2135178C1 (en) 1996-02-12 1996-02-12 Method of increasing antitumor efficiency in experiment

Country Status (1)

Country Link
RU (1) RU2135178C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2474430C1 (en) * 2011-11-15 2013-02-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт Минздравсоцразвития России" METHOD OF TREATING EXPERIMENTAL 3,4-BENZ(α)PYRENE INDUCED TUMOURS IN SPLENECTOMISED ANIMALS

Similar Documents

Publication Publication Date Title
PT932388E (en) DOSAGE AND METHOD FOR ADMINISTRATION OF DRUGS
CA2240329A1 (en) Improved delivery of multiple doses of medications
ATE216220T1 (en) OSMOTIC DOSAGE FORM WITH TWO LAYERS
IT1296980B1 (en) DOUBLE CAPSULE AS A PHARMACEUTICAL FORM FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS IN MULTIPLE THERAPIES
CA2304096A1 (en) Sustained-release liposomal anesthetic compositions
WO2001019337A3 (en) Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
ITRM930591A0 (en) MEDICAL DEVICE FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OR DRUGS AT VERY LOW DOSES, IN PARTICULAR HOMEOPATHIC DRUGS.
CA2294744A1 (en) Multiple unit effervescent dosage form
MX9203443A (en) A DOSAGE FORM FOR THE DELAYED DELIVERY OF A PHARMACY.
PT957899E (en) Dosage form for providing a medicament in a rising dose
AR008392A1 (en) PROCEDURE USING A GREEN PORPHYRIN TO PREPARE A MEDICINAL PRODUCT TO PREVENT OR INHIBIT ARTERIAL PLATE FORMATION AND PHARMACEUTICAL COMPOSITION OBTAINED BY SUCH PROCEDURE
ATE229337T1 (en) ANALGESICS CONTAINING A CHOLECYSTOKIN ANTAGONIST AND AN OPIOID
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
AU9190401A (en) Liposomes encapsulating anticancer drugs and the use thereof in the treatment ofmalignant tumors
RU96102509A (en) METHOD FOR INCREASING ANTITUMOR EFFICIENCY IN EXPERIMENT
RU2002103808A (en) METHOD FOR TREATING PAIN SYNDROME IN ONCOLOGIC PATIENTS
ES2099048T1 (en) USE OF ROPIVACAINE IN THE MANUFACTURE OF A PHARMACEUTICAL PRODUCT WITH ANALGESIC EFFECTS WITH MINIMUM MOTOR LOCK.
EP1384487A4 (en) Drugs containing genetically modified antibody against ganglioside gd3
CA2046448A1 (en) Dosage form for administering a drug to effect circadian therapy
RU99125650A (en) A method for the treatment of chronic tonsillitis
GEP20043348B (en) Pyrazolopyrimidinone Antianginal Agents
RU99126234A (en) METHOD FOR PREVENTION OF TOLERANCE TO NITRATES
ES2082524T3 (en) DELAYED RELEASE MEDICATION CONTAINING A DERIVATIVE OF DIHYDROPYRIDINE IN THE FORM OF NANOSOL AND ITS PREPARATION.
Tsukagoshi Hydrea, an effective drug for chronic myelogenous leukemia
UA33946A (en) Method for treating alcohol disease of liver